Browse All

Current Filters

CLEAR FILTER x

TITLE

Patterns of Medication Utilization and Migraine Frequency in Adults Using Rimegepant for Both Preventive and Acute Treatment for Migraine: Results From a 52-Week, Open-Label Extension Study

Pharmacokinetics, Disposition, and Biotransformation of 5 mg [14C]-Zavegepant in Healthy Male Subjects After a Single Intravenous Infusion Dose

Safety and Efficacy of Oral Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine in the Pediatric Population